Literature DB >> 20953576

Annexin 1 mimetic peptide protects against renal ischemia/reperfusion injury in rats.

Fernando N Facio1, Angela A Sena, Leandro P Araújo, Gloria E Mendes, Isac Castro, Marcus A M Luz, Luis Yu, Sonia Maria Oliani, Emmanuel A Burdmann.   

Abstract

Inflammation is currently recognized as a key mechanism in the pathogenesis of renal ischemia-reperfusion (I/R) injury. The importance of infiltrating neutrophil, lymphocytes, and macrophage in this kind of injury has been assessed with conflicting results. Annexin 1 is a protein with potent neutrophil anti-migratory activity. In order to evaluate the effects of annexin A1 on renal I/R injury, uninephrectomized rats received annexin A1 mimetic peptide Ac2-26 (100 μg) or vehicle before 30 min of renal artery clamping and were compared to sham surgery animals. Annexin A1 mimetic peptide granted a remarkable protection against I/R injury, preventing glomerular filtration rate and urinary osmolality decreases and acute tubular necrosis development. Annexin A1 infusion aborted neutrophil extravasation and attenuated macrophage infiltration but did not prevent tissue lymphocyte traffic. I/R increased annexin A1 expression (assessed by transmission electron microscopy) in renal epithelial cells, which was attenuated by exogenous annexin A1 infusion. Additionally, annexin A1 reduced I/R injury in isolated proximal tubules suspension. Annexin A1 protein afforded striking functional and structural protection against renal I/R. These results point to an important role of annexin A1 in the epithelial cells defense against I/R injury and indicate that neutrophils are key mediators for the development of tissue injury after renal I/R. If these results were confirmed in clinical studies, annexin A1 might emerge as an important tool to protect against I/R injury in renal transplantation and in vascular surgery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20953576     DOI: 10.1007/s00109-010-0684-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  53 in total

1.  Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment.

Authors:  M D'Amico; C Di Filippo; M La; E Solito; P G McLean; R J Flower; S M Oliani; M Perretti
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

2.  Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action.

Authors:  M La; M D'Amico; S Bandiera; C Di Filippo; S M Oliani; F N Gavins; R J Flower; M Perretti
Journal:  FASEB J       Date:  2001-10       Impact factor: 5.191

Review 3.  Annexins: linking Ca2+ signalling to membrane dynamics.

Authors:  Volker Gerke; Carl E Creutz; Stephen E Moss
Journal:  Nat Rev Mol Cell Biol       Date:  2005-06       Impact factor: 94.444

4.  Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes.

Authors:  Pierce Park; Mark Haas; Patrick N Cunningham; Lihua Bao; Jessy J Alexander; Richard J Quigg
Journal:  Am J Physiol Renal Physiol       Date:  2002-02

5.  Tacrolimus and nonsteroidal anti-inflammatory drugs: an association to be avoided.

Authors:  Rosa Maria C Soubhia; Glória Elisa F Mendes; Francine Zocoler Mendonça; Maria Alice S Baptista; José Paulo Cipullo; Emmanuel A Burdmann
Journal:  Am J Nephrol       Date:  2005-06-21       Impact factor: 3.754

6.  Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury.

Authors:  Gang Jee Ko; Chang-Su Boo; Sang-Kyung Jo; Won Yong Cho; Hyoung Kyu Kim
Journal:  Nephrol Dial Transplant       Date:  2007-11-05       Impact factor: 5.992

7.  Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1.

Authors:  L H Lim; E Solito; F Russo-Marie; R J Flower; M Perretti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  Effect of neutrophil depletion on ischemic renal injury in the rat.

Authors:  M S Paller
Journal:  J Lab Clin Med       Date:  1989-03

9.  Macrophage involvement in the kidney repair phase after ischaemia/reperfusion injury.

Authors:  E Vinuesa; G Hotter; M Jung; I Herrero-Fresneda; J Torras; A Sola
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

Review 10.  Annexin 1 and the biology of the neutrophil.

Authors:  Mauro Perretti; Roderick John Flower
Journal:  J Leukoc Biol       Date:  2004-02-13       Impact factor: 4.962

View more
  30 in total

1.  Knockdown of augmenter of liver regeneration in HK-2 cells inhibits inflammation response via the mitogen-activated protein kinase signaling pathway.

Authors:  Ruyu Yan; Ling Zhang; Ning Xia; Qi Liu; Hang Sun; Hui Guo
Journal:  Inflamm Res       Date:  2015-05-01       Impact factor: 4.575

2.  Annexin A1 protein attenuates cyclosporine-induced renal hemodynamics changes and macrophage infiltration in rats.

Authors:  Leandro Pires Araujo; Renata Ramos Truzzi; Gloria Elisa Florido Mendes; Marcus Alexandre Mendes Luz; Emmanuel A Burdmann; Sonia Maria Oliani
Journal:  Inflamm Res       Date:  2011-11-19       Impact factor: 4.575

3.  Annexin A1 is a Potential Novel Biomarker of Congestion in Acute Heart Failure.

Authors:  Fadi W Adel; Aruna Rikhi; Siu-Hin Wan; Seethalakshmi R Iyer; Hrishikesh Chakraborty; Steven McNulty; W H Wilson Tang; G Michael Felker; Michael M Givertz; Horng H Chen
Journal:  J Card Fail       Date:  2020-05-27       Impact factor: 5.712

4.  Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles.

Authors:  Nazila Kamaly; Gabrielle Fredman; Manikandan Subramanian; Suresh Gadde; Aleksandar Pesic; Louis Cheung; Zahi Adel Fayad; Robert Langer; Ira Tabas; Omid Cameron Farokhzad
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

5.  The Effect of Autophagy on Inflammation Cytokines in Renal Ischemia/Reperfusion Injury.

Authors:  Haibin Ling; Hongguang Chen; Miao Wei; Xiaoyin Meng; Yonghao Yu; Keliang Xie
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

6.  A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation.

Authors:  Vincenzo Brancaleone; Thomas Gobbetti; Nicolas Cenac; Pauline le Faouder; Bartomeu Colom; Roderick J Flower; Nathalie Vergnolle; Sussan Nourshargh; Mauro Perretti
Journal:  Blood       Date:  2013-06-03       Impact factor: 22.113

Review 7.  Obesity, immunomodulation and chronic kidney disease.

Authors:  Emma Börgeson; Kumar Sharma
Journal:  Curr Opin Pharmacol       Date:  2013-06-07       Impact factor: 5.547

8.  Gypenoside attenuates renal ischemia/reperfusion injury in mice by inhibition of ERK signaling.

Authors:  Qifa Ye; Y I Zhu; Shaojun Ye; Hong Liu; Xingguo She; Ying Niu; Yingzi Ming
Journal:  Exp Ther Med       Date:  2016-01-29       Impact factor: 2.447

9.  Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.

Authors:  Joost P Schanstra; Petra Zürbig; Alaa Alkhalaf; Angel Argiles; Stephan J L Bakker; Joachim Beige; Henk J G Bilo; Christos Chatzikyrkou; Mohammed Dakna; Jesse Dawson; Christian Delles; Hermann Haller; Marion Haubitz; Holger Husi; Joachim Jankowski; George Jerums; Nanne Kleefstra; Tatiana Kuznetsova; David M Maahs; Jan Menne; William Mullen; Alberto Ortiz; Frederik Persson; Peter Rossing; Piero Ruggenenti; Ivan Rychlik; Andreas L Serra; Justyna Siwy; Janet Snell-Bergeon; Goce Spasovski; Jan A Staessen; Antonia Vlahou; Harald Mischak; Raymond Vanholder
Journal:  J Am Soc Nephrol       Date:  2015-01-14       Impact factor: 10.121

10.  Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway.

Authors:  Xin Xu; Weiwei Gao; Lei Li; Jiheng Hao; Bin Yang; Tao Wang; Long Li; Xuesong Bai; Fanjian Li; Honglei Ren; Meng Zhang; Liyong Zhang; Jiyue Wang; Dong Wang; Jianning Zhang; Liqun Jiao
Journal:  J Neuroinflammation       Date:  2021-05-22       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.